BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Leard LE, Holm AM, Valapour M, Glanville AR, Attawar S, Aversa M, Campos SV, Christon LM, Cypel M, Dellgren G, Hartwig MG, Kapnadak SG, Kolaitis NA, Kotloff RM, Patterson CM, Shlobin OA, Smith PJ, Solé A, Solomon M, Weill D, Wijsenbeek MS, Willemse BWM, Arcasoy SM, Ramos KJ. Consensus document for the selection of lung transplant candidates: An update from the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 2021;40:1349-79. [PMID: 34419372 DOI: 10.1016/j.healun.2021.07.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Van Slambrouck J, Van Raemdonck D, Vos R, Vanluyten C, Vanstapel A, Prisciandaro E, Willems L, Orlitová M, Kaes J, Jin X, Jansen Y, Verleden GM, Neyrinck AP, Vanaudenaerde BM, Ceulemans LJ. A Focused Review on Primary Graft Dysfunction after Clinical Lung Transplantation: A Multilevel Syndrome. Cells 2022;11:745. [PMID: 35203392 DOI: 10.3390/cells11040745] [Reference Citation Analysis]
2 Franco-palacios DJ, Allenspach L, Stagner L, Pinto J, Olexsey K, Sherbin E, Dillon W, Sternberg D, Bryce K, Simanovski J, Apostolou D, Tanaka D, Nemeh H, Wang Z, Alangaden G. A center experience with lung transplantation for COVID-19 ARDS. Respiratory Medicine Case Reports 2022. [DOI: 10.1016/j.rmcr.2022.101597] [Reference Citation Analysis]
3 Hayes D, Melicoff-portillo E, Ziady AG. Selection of lung transplant candidates: A pediatric perspective on the International Society for Heart and Lung Transplantation consensus document. The Journal of Heart and Lung Transplantation 2022. [DOI: 10.1016/j.healun.2022.02.015] [Reference Citation Analysis]
4 Hamblin M, Prosch H, Vašáková M. Diagnosis, course and management of hypersensitivity pneumonitis. Eur Respir Rev 2022;31:210169. [PMID: 35140104 DOI: 10.1183/16000617.0169-2021] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Scheinin SA, Singh G, Loebe M. Adding complexity to complexity: The role of concomitant cardiac surgery in lung transplantation. J Card Surg 2022. [PMID: 35811494 DOI: 10.1111/jocs.16743] [Reference Citation Analysis]
6 Martin C, Reynaud-gaubert M, Hamidfar R, Durieu I, Murris-espin M, Danner-boucher I, Chiron R, Leroy S, Douvry B, Grenet D, Mely L, Ramel S, Montcouquiol S, Lemonnier L, Burnet E, Paillasseur J, Da Silva J, Burgel P. Sustained effectiveness of elexacaftor-tezacaftor-ivacaftor in lung transplant candidates with cystic fibrosis. Journal of Cystic Fibrosis 2022. [DOI: 10.1016/j.jcf.2022.01.012] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
7 Ehrsam JP, Schuurmans MM, Laager M, Opitz I, Inci I. Recipient Comorbidities for Prediction of Primary Graft Dysfunction, Chronic Allograft Dysfunction and Survival After Lung Transplantation. Transpl Int 2022;35:10451. [DOI: 10.3389/ti.2022.10451] [Reference Citation Analysis]
8 Jennerich AL, Pryor JB, Wai TYH, Kapnadak SG, Aitken ML, Goss CH, Ramos KJ. Low body mass index as a barrier to lung transplant in cystic fibrosis. J Cyst Fibros 2021:S1569-1993(21)02159-7. [PMID: 34922852 DOI: 10.1016/j.jcf.2021.12.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Brzezinski M, Mladinov D, Neyrinck A. Anesthetic Management During Lung Transplantation - What's New in 2021? Thorac Surg Clin 2022;32:175-84. [PMID: 35512936 DOI: 10.1016/j.thorsurg.2022.01.001] [Reference Citation Analysis]
10 Tolle LB. Challenges in the Diagnosis and Management of Patients with Fibrosing Interstitial Lung Disease. Case Rep Pulmonol 2022;2022:9942432. [PMID: 35211349 DOI: 10.1155/2022/9942432] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Sehgal S, Mangukia C, Toyoda Y, Cordova F. The art of lung transplantation—lessons learnt from one thousand lung transplants. Indian J Thorac Cardiovasc Surg. [DOI: 10.1007/s12055-021-01314-x] [Reference Citation Analysis]
12 Just IA, Fries D, Loewe S, Falk V, Cesarovic N, Kemper D, Edelmann F, Feuerstein A, Haufe FL, Xiloyannis M, Riener R, Schoenrath F. Movement therapy in lung transplantation candidates assisted by a lightweight wearable robot. Assist Technol 2022. [PMID: 35438604 DOI: 10.1080/10400435.2022.2067914] [Reference Citation Analysis]
13 Nagata S, Ohsumi A, Handa T, Yamada Y, Tanaka S, Yutaka Y, Nakajima D, Tanizawa K, Hirai T, Date H. Assessment of listing criteria for lung transplant candidates with interstitial lung disease. Gen Thorac Cardiovasc Surg. [DOI: 10.1007/s11748-022-01861-z] [Reference Citation Analysis]
14 Pflaum M, Jurmann S, Katsirntaki K, Mälzer M, Haverich A, Wiegmann B. Towards Biohybrid Lung Development-Fibronectin-Coating Bestows Hemocompatibility of Gas Exchange Hollow Fiber Membranes by Improving Flow-Resistant Endothelialization. Membranes (Basel) 2021;12:35. [PMID: 35054561 DOI: 10.3390/membranes12010035] [Reference Citation Analysis]
15 Winder GS, Andrews SR, Banerjee AG, Hussain F, Ivkovic A, Kuntz K, Omary L, Shenoy A, Thant T, VandenBerg A, Zimbrean P. Cannabinoids and solid organ transplantation: Psychiatric perspectives and recommendations. Transplant Rev (Orlando) 2022;36:100715. [PMID: 35853383 DOI: 10.1016/j.trre.2022.100715] [Reference Citation Analysis]
16 Christon LM, Smith PJ. Psychosocial Evaluation for Lung Transplantation: an Empirically Informed Update. Curr Transpl Rep. [DOI: 10.1007/s40472-022-00360-7] [Reference Citation Analysis]
17 Olson MT, Elnahas S, Biswas Roy S, Razia D, Kang P, Bremner RM, Smith MA, Arjuna A, Walia R. Outcomes after lung transplantation in recipients aged 70 years or older. Clin Transplant 2021;:e14505. [PMID: 34634161 DOI: 10.1111/ctr.14505] [Reference Citation Analysis]
18 Singh N, Dorfmüller P, Shlobin OA, Ventetuolo CE. Group 3 Pulmonary Hypertension: From Bench to Bedside. Circ Res 2022;130:1404-22. [PMID: 35482836 DOI: 10.1161/CIRCRESAHA.121.319970] [Reference Citation Analysis]
19 Khangoora VS, King CS, Shlobin OA. Managing pulmonary arterial hypertension: how to select and facilitate successful transplantation. Curr Opin Organ Transplant 2022;27:169-76. [PMID: 35649107 DOI: 10.1097/MOT.0000000000000980] [Reference Citation Analysis]
20 Patterson CM, Shah A, Rabin J, Dichiacchio L, Cypel M, Hoetzenecker K, Catarino P, Lau CL. EXTRACORPOREAL LIFE SUPPORT AS A BRIDGE TO LUNG TRANSPLANTATION: WHERE ARE WE NOW? The Journal of Heart and Lung Transplantation 2022. [DOI: 10.1016/j.healun.2022.06.004] [Reference Citation Analysis]
21 Vicaire H, Pavec JL, Mercier O, Montani D, Boucly A, Roche A, Pradère P, Dauriat G, Feuillet S, Pichon J, Jevnikar M, Beurnier A, Jaïs X, Fadel E, Sitbon O, Humbert M, Savale L. Risk stratification in patients with pulmonary arterial hypertension at the time of listing for lung transplantation. The Journal of Heart and Lung Transplantation 2022. [DOI: 10.1016/j.healun.2022.06.001] [Reference Citation Analysis]
22 Mora Cuesta VM, Vargas NB, Fernández DI, Mena ST, Cifrián Martínez JM. Exacerbation of chronic renal failure because of inhaled tobramycin in a lung transplant patient. Respiratory Medicine Case Reports 2022. [DOI: 10.1016/j.rmcr.2022.101584] [Reference Citation Analysis]
23 Koutsokera A, Sykes J, Theou O, Rockwood PK, Steinack C, Derkenne M, Benden PC, Krueger PT, Chaparro C, Aubert PJ, Gasche PPS, von Garnier PC, Tullis PE, Stephenson AL, Singer PLG. FRAILTY PREDICTS OUTCOMES IN CYSTIC FIBROSIS PATIENTS LISTED FOR LUNG TRANSPLANTATION. The Journal of Heart and Lung Transplantation 2022. [DOI: 10.1016/j.healun.2022.07.017] [Reference Citation Analysis]
24 Lehr CJ, Wey A, Skeans MA, Lease ED, Valapour M. Impact of Incorporating Long-term Survival for Calculating Transplant Benefit in the US Lung Transplant Allocation System. The Journal of Heart and Lung Transplantation 2022. [DOI: 10.1016/j.healun.2022.02.012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Lashari BH, Myers C, Brown J, Galli J, Sehgal S. Recipient selection, timing of referral, and listing for lung transplantation. Indian J Thorac Cardiovasc Surg. [DOI: 10.1007/s12055-022-01330-5] [Reference Citation Analysis]
26 Glanville AR. Editorial: Current opinion in organ transplantation: lung transplantation. Curr Opin Organ Transplant 2022;27:167-8. [PMID: 35649106 DOI: 10.1097/MOT.0000000000000985] [Reference Citation Analysis]
27 Karolak W, Pastwa K, Addo SA, Khan S, Shinde R, Nuur IM, Kumaravel A, Reta FK, Wojarski J, Maruszewski M, Woźniak-grygiel E, Chmielecki M, Frankiewicz A, Nagajewski A, Abba ME, Łącka M, Żeglen S. Routine Coronary Angiography is Still the Key Test for Patients Eligible for Lung Transplantation Also for Those With No Symptoms and With High Risk of Coronary Artery Disease. Transplantation Proceedings 2022. [DOI: 10.1016/j.transproceed.2022.02.049] [Reference Citation Analysis]
28 Soder SA, Fontena E, Salgado JC, Shahmohammadi A, Samano MN, Machuca TN. Inpatient Management of the Acutely Decompensating Lung Transplant Candidate. Thorac Surg Clin 2022;32:121-34. [PMID: 35512931 DOI: 10.1016/j.thorsurg.2022.02.001] [Reference Citation Analysis]
29 Koons B, Anderson MR, Smith PJ, Greenland JR, Singer JP. The Intersection of Aging and Lung Transplantation: its Impact on Transplant Evaluation, Outcomes, and Clinical Care. Curr Transpl Rep. [DOI: 10.1007/s40472-022-00365-2] [Reference Citation Analysis]
30 Sayah DM, Pilewski JM. Outpatient Pharmacologic Management of Lung Transplant Candidates on the Waiting List. Thorac Surg Clin 2022;32:111-9. [PMID: 35512930 DOI: 10.1016/j.thorsurg.2022.01.002] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
31 Latos M, Urlik M, Nęcki M, Pawlak D, Niepokój K, Stącel T, Zawadzki F, Przybyłowski P, Ochman M. Influence of Bronchoscopic Interventions on Graft Function of Double Lung Transplant Recipients due to Cystic Fibrosis. Transplant Proc 2022:S0041-1345(22)00173-7. [PMID: 35459464 DOI: 10.1016/j.transproceed.2022.02.041] [Reference Citation Analysis]
32 Latos M, Nęcki M, Urlik M, Pawlak D, Niepokój K, Stącel T, Zawadzki F, Przybyłowski P, Ochman M. Effect of Bronchoscopic Interventions on Long-Term Lung Function Among Lung Transplant Recipients due to Cystic Fibrosis: A Single-Center Study. Transplantation Proceedings 2022. [DOI: 10.1016/j.transproceed.2022.02.059] [Reference Citation Analysis]
33 Kuczewski M, Wasson K, Hutchison PJ, Dilling DF. Putting ethics and clinical decision making before politics: requiring COVID-19 immunization for Solid Organ Transplantation (SOT) Candidates and their Support Team. J Heart Lung Transplant 2021:S1053-2498(21)02539-0. [PMID: 34799246 DOI: 10.1016/j.healun.2021.10.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
34 Urlik M, Stącel T, Latos M, Nęcki M, Zawadzki F, Pasek P, Przybyłowski P, Ochman M. Results of Lung Transplantations Among Cystic Fibrosis Patients: A Single-Center Study. Transplantation Proceedings 2022. [DOI: 10.1016/j.transproceed.2022.02.056] [Reference Citation Analysis]
35 Hansmann G, Diekmann F, Chouvarine P, Ius F, Carlens J, Schwerk N, Warnecke G, Vogel-Claussen J, Hohmann D, Alten T, Jack T. Full recovery of right ventricular systolic function in children undergoing bilateral lung transplantation for severe PAH. J Heart Lung Transplant 2021:S1053-2498(21)02568-7. [PMID: 34955331 DOI: 10.1016/j.healun.2021.10.014] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]